A detailed history of Stenham Asset Management LTD transactions in Mannkind Corp stock. As of the latest transaction made, Stenham Asset Management LTD holds 748,700 shares of MNKD stock, worth $3.41 Million. This represents 1.53% of its overall portfolio holdings.

Number of Shares
748,700
Holding current value
$3.41 Million
% of portfolio
1.53%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$4.92 - $6.6 $3.68 Million - $4.94 Million
748,700 New
748,700 $3.77 Billion

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.17B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Stenham Asset Management LTD Portfolio

Follow Stenham Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stenham Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Stenham Asset Management LTD with notifications on news.